GeneDx Holdings (WGS) Margins & Profitability 2020-2026

Gross, EBITDA, operating, and net margin trends

Margins

Profit margins across the income statement

Gross Margin: 66.7%
EBITDA Margin: -49.5%
Op. Margin: -56.2%
Net Margin: -61.9%

Op. margin of -56.2% is down 51.0% YoY — costs are rising relative to revenue. Net margin at -61.9% and gross margin of 66.7% — earnings take a bigger bite when COGS stays lean..

Gross Margin (%)

Revenue left after direct cost of goods sold

EBITDA Margin (%)

Operating profitability independent of capital structure

Operating & Net Margins (%)

How much of each dollar becomes profit